Search by Drug Name or NDC
NDC 49035-0273-30 Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1 Details
Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1
Fexofenadine HCl and Pseudoephedrine HCI is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Wal-mart Stores Inc.. The primary component is FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
The combination of fexofenadine and pseudoephedrine is used in adults and children 12 years of age and older to relieve the allergy symptoms of seasonal allergic rhinitis ('hay fever'), including runny nose; sneezing; congestion (stuffy nose); red, itchy, or watery eyes; or itching of the nose, throat, or roof of the mouth. Fexofenadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms. Pseudoephedrine is in a class of medications called decongestants. It works by drying up the nasal passages.
Related Packages: 49035-0273-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fexofenadine and Pseudoephedrine
Product Information
| NDC | 49035-0273 |
|---|---|
| Product ID | 49035-273_89a65237-243f-d6ec-f917-07450a7670b2 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Fexofenadine HCl and Pseudoephedrine HCI |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fexofenadine HCl and Pseudoephedrine HCI |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 60; 120 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Labeler Name | Wal-mart Stores Inc. |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076667 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49035-0273-30 (49035027330)
| NDC Package Code | 49035-273-30 |
|---|---|
| Billing NDC | 49035027330 |
| Package | 6 BLISTER PACK in 1 CARTON (49035-273-30) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| Marketing Start Date | 2019-12-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |